18 May 2013
Keywords: ligand, buys, down, ontak, royalties, usa, pharmaceuticals
Article | 18 April 2005
The USA's Ligand Pharmaceuticals has exercised the final option under its November 2004 agreement with US drug major Eli Lilly to ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
18 April 2005
17 May 2013
© 2013 thepharmaletter.com